Soheil Tavakolpour

Soheil Tavakolpour

(Last update: 11, May 11, 2017)

-Email:

[email protected]

[email protected]

-Homepage:

www.Tavakolpour.ir

-Researchgate profile: www.researchgate.net/profile/Soheil_Tavakolpour

-ORCID profile: 0000-0002-6765-8830

-Scopus profile:
https://www.scopus.com/authid/detail.uri?authorId=56938752500

-Google scholar profile:
https://scholar.google.com/citations?user=bUDxjAsAAAAJ&hl=en

-Total number of ISI/PubMed indexed articles: 24

• Number of first author ISI/PubMed indexed articles:
  23
• Number of corresponding author ISI/PubMed indexed articles:
  19

-Education

Molecular genetics, MSc, The Islamic Azad University, Science and Research Branch (SRBIAU) (2015-2017),
Tehran, Iran.

-PubMed indexed article list

1. Tavakolpour S. Inhibition of regulatory cells as a possible cure of chronically hepatitis B virus infected patients. Immunology letters. 2016;171:70.



2. Tavakolpour S. Dupilumab: a revolutionary emerging drug in atopic dermatitis and its possible role in pemphigus. Dermatologic therapy. 2016.



3. Tavakolpour S. Anti-interleukin and associated receptors monoclonal antibodies therapy in autoimmune diseases. Receptors & Clinical Investigation. 2016;3(1).



4. Tavakolpour S. The new insight into management of hepatitis b virus patients with flare. Immunology letters. 2016.

5. Tavakolpour S. Interleukin 21 as a new possible player in pemphigus: Is it a suitable target? International immunopharmacology. 2016;34:139-45.



6. Tavakolpour S. Janus kinase inhibitors against other biological treatments in alopecia areata. Scandinavian journal of immunology. 2016.



7. Tavakolpour S. Interleukin 7 receptor polymorphisms and the risk of multiple sclerosis: A meta-analysis. Multiple Sclerosis and Related Disorders. 2016;8:66-73.



8. Tavakolpour S. The role of intravenous immunoglobulin in treatment of mucous membrane pemphigoid: A review of literature. Journal of Research in Medical Sciences. 2016;21(3).



9. Tavakolpour S. Changes in induced regulatory T cells by interleukin 35 during atopic dermatitis. Anais brasileiros de dermatologia. 2016;91(5):703-.



10. Tavakolpour S, Alavian SM, Sali S. Hepatitis B Reactivation During Immunosuppressive Therapy or Cancer Chemotherapy, Management, and Prevention: A Comprehensive Review-Screened. Hepatitis monthly. 2016;16(4).



11. Tavakolpour S, Alavian SM, Sali S. Manipulation of Regulatory Cells’ Responses to Treatments for Chronic Hepatitis B Virus infection. Hepatitis Monthly. 2016(In Press).



12. Tavakolpour S, Daneshpazhooh M, Mahmoudi H. Blockage of T Cell Activation via Anti‐CD40 and Anti‐CD154 Monoclonal Antibodies can Possibility Treat Alopecia Areata. Scandinavian journal of immunology. 2016;83(6):463-4.



13. Tavakolpour S, Daneshpazhooh M, Mahmoudi HR, Balighi K. The dual nature of retinoic acid in pemphigus and its therapeutic potential: Special focus on all-trans Retinoic Acid. International immunopharmacology. 2016;36:180-6.



14. Tavakolpour S, Kheiry F, Mirsafaei HS, Akhlaghdoust M. The possible role of interleukin-35 and its therapeutic potential in pemphigus. International Immunopharmacology. 2017;42:11-7.



15. Tavakolpour S, Mahmoudi H, Daneshpazhooh M, Rahimzadeh G. Complex Interaction Between Diphenylcyclopropenone and Immune Responses in Alopecia Areata. Scandinavian Journal of Immunology. 2016;84(5):310-1.



16. Tavakolpour S, Mirsafaei HS, Delshad S. Management of pemphigus disease in pregnancy. American Journal of Reproductive Immunology. 2016.



17. Tavakolpour S, Rahimzadeh G. New Insights into the Management of Patients with Autoimmune Diseases orInflammatory Disorders During Pregnancy. Scandinavian journal of immunology. 2016;84(3):146–9.

18. Tavakolpour S, Sali S. Tumor Necrosis Factor-α-308 G/A Polymorphisms and Risk of Hepatocellular Carcinoma: A Meta-Analysis. Hepatitis monthly. 2016;16(4).



19. Tavakolpour S, Sali S, Gachkar L. Association of Plasma Levels of Vitamin D With Chronic Hepatitis B Infection. Hepatitis monthly. 2016;16(1).



20. Tavakolpour S, Tavakolpour V. Interleukin 4 inhibition as a potential therapeutic in pemphigus. Cytokine. 2016;77:189-95.



21. Sali S, Tavakolpour S, Farkhondemehr B. Comparison of Vitamin D Levels in Naive, Treated, and Inactive Carriers with Chronic Hepatitis B Virus. Journal of Clinical and Translational Hepatology. 2016;4(4):306-309. doi:10.14218/JCTH.2016.00037.



22. Tavakolpour S. (2017), Regulatory responses during chronic hepatitis B virus infection. Scand J Immunol. Accepted Author Manuscript. doi:10.1111/sji.12527.



23. Tavakolpour S, Soori T, Noormohammadpoor P, Balighi K, Mahmoudi HR, Daneshpazhooh M. Rituximab administration in a patient with pemphigus vulgaris following reactivation of occult hepatitis B virus infection. Dematol Online, 2017 (In press).



24. Tavakolpour S. The ignored roles of microRNAs in alopecia areata. Dermatologic Therapy. 2017;00: e12488.https://doi.org/10.1111/dth.12488 (In press).

-Journals' reviewer

    · 

•  PLOS ONE (Journal Impact: 3.54)

• Dermatologic Therapy (Journal Impact: 1.268)
• Journal of Medical Case Reports (Journal Impact: 0.69)
• Anti-Infective Agents

-Editorial board member

• EC Neurology
  
  
  
  • EC Pharmacology and Toxicology
  
  

-Information Technology

• Expert in Meta-analysis and systematic review
• Perfect command of Microsoft Office 
• High internet and operating systems skills
• Expert in End Note
• Fluent English
• Scientific writing

 -Cooperation

• Cooperation with Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran
• Cooperation with Baqiyatallah Research Center for Gastroenterology and Liver Diseases, Baqyiatallah University of Medical Sciences, Tehran, IR Iran
• Cooperation with Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran